Financial Personal
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team
Annual General Meeting elects new Board of Directors: Dr. Frederick D. Sancilio, Dr. Harry Jacobson and Mr. Wesley Ramjeet Board announces resignations of CEO Philip Young and COO Baxter Phillips III The Board of Directors appoints Dr. Frederick D. S
VANCOUVER, British Columbia -- Lobe Sciences Ltd ("Lobe Sciences" or the "Company") (CSE: LOBE), (OTCQB: LOBEF), a biopharmaceutical company focused on developing products to treat diseases with unmet medical needs, today announced that a new board of directors (“Board”) has been elected at the Company’s annual general meeting, with shareholders electing the three previously announced nominees: Dr. Frederick D. Sancilio, Dr. Harry Jacobson and Mr. Wesley Ramjeet. Lobe Sciences also announces that Mr. Philip Young and Mr. Baxter Phillips have elected to leave the Company to pursue other opportunities. The Board has appointed Dr. Sancilio as Chairman of the Board and Chief Executive Officer of the Company. Read More
